184 related articles for article (PubMed ID: 30359562)
1. Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.
Oda T; Yamamoto T; Kato T; Uchinoumi H; Fukui G; Hamada Y; Nanno T; Ishiguchi H; Nakamura Y; Okamoto Y; Kono M; Okuda S; Kobayashi S; Bers DM; Yano M
J Mol Cell Cardiol; 2018 Dec; 125():87-97. PubMed ID: 30359562
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of ryanodine receptor (RyR) and calmodulin enhance Ca release and pathologically alter, RyR structure and calmodulin affinity.
Oda T; Yang Y; Uchinoumi H; Thomas DD; Chen-Izu Y; Kato T; Yamamoto T; Yano M; Cornea RL; Bers DM
J Mol Cell Cardiol; 2015 Aug; 85():240-8. PubMed ID: 26092277
[TBL] [Abstract][Full Text] [Related]
3. CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift.
Uchinoumi H; Yang Y; Oda T; Li N; Alsina KM; Puglisi JL; Chen-Izu Y; Cornea RL; Wehrens XHT; Bers DM
J Mol Cell Cardiol; 2016 Sep; 98():62-72. PubMed ID: 27318036
[TBL] [Abstract][Full Text] [Related]
4. Nuclear translocation of cardiac G protein-Coupled Receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process.
Gold JI; Martini JS; Hullmann J; Gao E; Chuprun JK; Lee L; Tilley DG; Rabinowitz JE; Bossuyt J; Bers DM; Koch WJ
PLoS One; 2013; 8(3):e57324. PubMed ID: 23472081
[TBL] [Abstract][Full Text] [Related]
5. Intracellular translocation of calmodulin and Ca2+/calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes.
Gangopadhyay JP; Ikemoto N
Biochem Biophys Res Commun; 2010 May; 396(2):515-21. PubMed ID: 20433809
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure.
Ono M; Yano M; Hino A; Suetomi T; Xu X; Susa T; Uchinoumi H; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Koseki N; Kyushiki H; Ikemoto N; Matsuzaki M
Cardiovasc Res; 2010 Sep; 87(4):609-17. PubMed ID: 20388639
[TBL] [Abstract][Full Text] [Related]
7. Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure.
Yang Y; Guo T; Oda T; Chakraborty A; Chen L; Uchinoumi H; Knowlton AA; Fruen BR; Cornea RL; Meissner G; Bers DM
Circ Res; 2014 Jan; 114(2):295-306. PubMed ID: 24186966
[TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum stress promotes nuclear translocation of calmodulin, which activates phenotypic switching of vascular smooth muscle cells.
Uchida T; Oda T; Yamamoto T; Inamitsu M; Sakai C; Uchinoumi H; Suetomi T; Nakamura Y; Okamoto Y; Tateda S; Fujii S; Tanaka S; Nawata J; Okamura T; Kobayashi S; Yano M
Biochem Biophys Res Commun; 2022 Nov; 628():155-162. PubMed ID: 36099691
[TBL] [Abstract][Full Text] [Related]
9. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction.
Xu X; Yano M; Uchinoumi H; Hino A; Suetomi T; Ono M; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ikemoto N; Matsuzaki M
Biochem Biophys Res Commun; 2010 Apr; 394(3):660-6. PubMed ID: 20226167
[TBL] [Abstract][Full Text] [Related]
10. Enhancing calmodulin binding to cardiac ryanodine receptor completely inhibits pressure-overload induced hypertrophic signaling.
Kohno M; Kobayashi S; Yamamoto T; Yoshitomi R; Kajii T; Fujii S; Nakamura Y; Kato T; Uchinoumi H; Oda T; Okuda S; Watanabe K; Mizukami Y; Yano M
Commun Biol; 2020 Nov; 3(1):714. PubMed ID: 33244105
[TBL] [Abstract][Full Text] [Related]
11. Stabilizing cardiac ryanodine receptor with dantrolene treatment prevents left ventricular remodeling in pressure-overloaded heart failure mice.
Yano Y; Kobayashi S; Uchida T; Chang Y; Nawata J; Fujii S; Nakamura Y; Suetomi T; Uchinoumi H; Oda T; Yamamoto T; Yano M
Biochem Biophys Res Commun; 2023 Jan; 642():175-184. PubMed ID: 36584481
[TBL] [Abstract][Full Text] [Related]
12. FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel.
Guo T; Fruen BR; Nitu FR; Nguyen TD; Yang Y; Cornea RL; Bers DM
Biophys J; 2011 Nov; 101(9):2170-7. PubMed ID: 22067155
[TBL] [Abstract][Full Text] [Related]
13. Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1.
Yamaguchi N; Chakraborty A; Huang TQ; Xu L; Gomez AC; Pasek DA; Meissner G
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H86-94. PubMed ID: 23666671
[TBL] [Abstract][Full Text] [Related]
14. Ca(2+)-calmodulin can activate and inactivate cardiac ryanodine receptors.
Sigalas C; Bent S; Kitmitto A; O'Neill S; Sitsapesan R
Br J Pharmacol; 2009 Mar; 156(5):794-806. PubMed ID: 19220289
[TBL] [Abstract][Full Text] [Related]
15. RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
Fujii S; Kobayashi S; Chang Y; Nawata J; Yoshitomi R; Tanaka S; Kohno M; Nakamura Y; Ishiguchi H; Suetomi T; Uchinoumi H; Oda T; Okuda S; Okamura T; Yamamoto T; Yano M
J Mol Cell Cardiol; 2023 May; 178():36-50. PubMed ID: 36963751
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of calmodulin regulation of RyR2 in controlling heart rhythm, the progression of heart failure and the antiarrhythmic action of dantrolene.
Walweel K; Oo YW; Laver DR
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):135-142. PubMed ID: 27626620
[TBL] [Abstract][Full Text] [Related]
17. Enhancing calmodulin binding to ryanodine receptor is crucial to limit neuronal cell loss in Alzheimer disease.
Nakamura Y; Yamamoto T; Xu X; Kobayashi S; Tanaka S; Tamitani M; Saito T; Saido TC; Yano M
Sci Rep; 2021 Mar; 11(1):7289. PubMed ID: 33790404
[TBL] [Abstract][Full Text] [Related]
18. Stabilizing cardiac ryanodine receptor prevents the development of cardiac dysfunction and lethal arrhythmia in Ca
Sufu-Shimizu Y; Okuda S; Kato T; Nishimura S; Uchinoumi H; Oda T; Kobayashi S; Yamamoto T; Yano M
Biochem Biophys Res Commun; 2020 Apr; 524(2):431-438. PubMed ID: 32007269
[TBL] [Abstract][Full Text] [Related]
19. The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor.
Søndergaard MT; Liu Y; Larsen KT; Nani A; Tian X; Holt C; Wang R; Wimmer R; Van Petegem F; Fill M; Chen SR; Overgaard MT
J Biol Chem; 2017 Jan; 292(4):1385-1395. PubMed ID: 27927985
[TBL] [Abstract][Full Text] [Related]
20. Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel.
Yamaguchi N; Takahashi N; Xu L; Smithies O; Meissner G
J Clin Invest; 2007 May; 117(5):1344-53. PubMed ID: 17431507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
